Previous Article | Next Article ![]()
Journal of Virology, September 2000, p. 8077-8084, Vol. 74, No. 17
Laboratory of Cellular and Molecular
Biophysics, National Institute of Child Health and Human
Development, National Institutes of Health, Bethesda, Maryland 20892
Received 21 September 2000/Accepted 8 June 2000
Progression of human immunodeficiency virus (HIV) disease is
associated with massive death of CD4+ T cells along with
death and/or dysfunction of CD8+ T cells. In vivo, both HIV
infection per se and host factors may contribute to the death and/or
dysfunction of CD4+ and CD8+ T cells.
Progression of HIV disease is often characterized by a switch from R5
to X4 HIV type 1 (HIV-1) variants. In human lymphoid tissues ex vivo,
it was shown that HIV infection is sufficient for CD4+
T-cell depletion. Here we address the question of whether infection of
human lymphoid tissue ex vivo with prototypic R5 or X4 HIV variants
also depletes or impairs CD8+ T cells. We report that
whereas productive infection of lymphoid tissue ex vivo with R5 and X4
HIV-1 isolates induced apoptosis in CD4+ T cells,
neither viral isolate induced apoptosis in CD8+ T
cells. Moreover, in both infected and control tissues we found similar
numbers of CD8+ T cells and similar production of cytokines
by these cells in response to phorbol myristate acetate or
anti-CD3-anti-CD28 stimulation. Thus, whereas HIV-1 infection per se
in human lymphoid tissue is sufficient to trigger apoptosis in
CD4+ T cells, the death of CD8+ T cells
apparently requires additional factors.
0022-538X/00/$04.00+0
Human Immunodeficiency Virus Type 1 Induces Apoptosis in
CD4+ but Not in CD8+ T Cells in Ex
Vivo-Infected Human Lymphoid Tissue
*
Corresponding author. Mailing address: NIH, Bldg. 10, Rm. 10D14, Bethesda, MD 20892. Phone: (301) 594-2476. Fax: (301)
480-0857. E-mail: margolis{at}helix.nih.gov.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|